undamentalytics Newsletter

Ferree Deborah L: insider trades

Officer at Designer Brands Inc. 1 open-market purchase and 19 sales not made under a pre-set plan, reported from December 5, 2012 to December 12, 2025.

Would copying Ferree Deborah L’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on June 9, 2014 into $17,732 by November 2, 2026, +4.7% a year. The copy held shares only 5% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $13,557, +2.5% a year (the S&P 500 held throughout made $47,649, +13.4% a year). Beta against the index was 0.02. Twelve months after each report, the average purchase was +21.0% against the S&P 500 (median +21.0%), and 100% beat it. Measured from the trade date, the insider’s own timing, the average was +30.7%. After their sales, the shares moved −23.1% against the index over 12 months on average (a negative figure means selling was the right call); 78% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k 2014201620182020202220242026 $47.6k$17.7k$13.6k
Copying Ferree Deborah LS&P 500, same days investedS&P 500, held throughout $10,000 copying Ferree Deborah L’s open-market purchases from June 9, 2014, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+4.7%
S&P 500, same days invested
+2.5% (held throughout +13.4%)
Time in shares
5%
Sharpe ratio (S&P 500)
0.47 (0.70)
Biggest drop (S&P 500)
−9% (−34%)
Market sensitivity (beta)
0.02
Purchases copied
1

Trade by trade

Ferree Deborah L: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +8.3% +8.3% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 +19.7% +19.7% 100% 1 — — Not enough years
Purchases, 12 months after the report 1 +21.0% +21.0% 100% 1 — — Not enough years
Purchases, 12 months after the trade 1 +30.7% +30.7% 100% 1 — — Not enough years
Sales, 3 months after the report 19 −4.9% −8.1% 74% 11 −0.16 0.88 No reliable evidence
Sales, 12 months after the report 18 −23.1% −30.8% 78% 10 −1.21 0.26 No reliable evidence
Sales, 12 months after the trade 18 −25.4% −32.6% 72% 10 −1.39 0.20 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Designer Brands Inc. DBI V. Chair; Ch Product Off119December 5, 2012December 12, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
December 12, 2025December 11, 2025 DBI Sale $1,146,753 −34.7%not yetnot yet
September 12, 2023September 8, 2023 DBI Sale $1,807,500 −31.8%−77.1%−75.6%
July 13, 2023July 11, 2023 DBI Sale $545,298 +26.4%−49.1%−58.3%
September 12, 2022September 9, 2022 DBI Sale $1,176,421 −40.3%−40.5%−40.6%
September 29, 2021September 27, 2021 DBI Sale $1,116,750 −6.8%+26.5%+15.2%
March 25, 2021March 23, 2021 DBI Sale $1,443,495 +3.7%−28.9%−26.7%
December 14, 2020December 10, 2020 DBI Sale $32,118 +108.4%+60.4%+66.7%
December 23, 2019December 23, 2019 DBI Sale $155,500 −39.1%−68.6%−70.7%
September 9, 2019September 6, 2019 DBI Sale $1,142,724 −4.6%−78.2%−72.2%
June 11, 2019June 7, 2019 DBI Sale $1,320,900 −8.1%−66.7%−63.0%
September 28, 2017September 27, 2017 DBI Sale $216,872 −6.1%+45.7%+46.5%
August 28, 2017August 25, 2017 DBI Sale $1,509,040 +2.6%+58.4%+20.6%
November 28, 2016November 23, 2016 DBI Sale $2,857,568 −18.4%−27.0%−34.7%
September 24, 2015September 22, 2015 DBI Sale $256,380 −16.2%−32.7%−35.4%
March 24, 2015March 20, 2015 DBI Sale $1,374,612 −10.7%−27.5%−26.5%
March 20, 2015March 18, 2015 DBI Sale $2,664,784 −10.4%−26.3%−25.4%
January 12, 2015January 8, 2015 DBI Sale $4,940,687 −5.5%−33.1%−30.4%
June 6, 2014June 4, 2014 DBI Purchase $514,400 +8.3%+21.0%+30.7%
July 12, 2013July 11, 2013 DBI Sale $1,188,291 +6.4%−48.8%−48.4%
December 5, 2012December 3, 2012 DBI Sale $4,086,801 −8.4%−2.6%+2.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Ferree Deborah L traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.